PNEUMOCOCCAL INFECTION: MODERN VIEW ON THE ISSUE AND PREVENTION

PNEUMOCOCCAL INFECTION: MODERN VIEW ON THE ISSUE AND PREVENTION

Blog Article

Pneumococci are spread everywhere and they are very often a component of the microflora of the upper respiratory tracts.The level of the pneumococcus carriage is correlated with age.Among children the highest frequency is observed at the age of 4,5 years (up to 90% of cases), among adults it is 5–10%.According to international and Russian data, pneumococcal infection causes up to 76% of all the aetiologically deciphered cases of community cacquired pneumonia among adults and up to 94% (aggravated cases) among children.The most frequent clinical forms of pneumococcal infection among children are acute otitis media (over 30%), pneumonia and meningitis (about 5–20% of all purulent bacterial meningitis), among adults — meningitis and sepsis.

In 1998, in Russia was registered the first and still the only vaccine for the prevention of pneumococcal infection — Pneumo 23 tonic shower cap (Sanofi Pasteur).The vaccine consists of 23 antic gens of the most dangerous pneumococcus serotypes and is used for the prevention of all the forms of pneumococcal infection.The composition of Pneumo 23 corresponds to 85% of pneumococcus serotypes circulating across Europe and to 90% serotypes resistant to penicillin.According to Russian data Pneumo 23 consists of redken shades 9gi about 80% of pneumococcus serotypes isolated in healthy carriers and ill with acute respiratory diseases and of 92% of serotypes in those suffering from acute bronchitis and pneumonia.The results of the clinical studies allow us to recommend the use of the given vaccine in a complex therapy of children, suffering from latent TB infection, often recurrent episodes of bronchopulmonary pathologies, ENT diseases, bronchial asthma and other chronic diseases.


Key words: therapy, pediatrics, pneumonia, bronchial asthma, chronic obstructive lungs disease, prevention, treatment, pneumococcal infection..